Gave up on GERN($3.70) for now
Great rally from $1.70 to $4, and decided to bail around $3.80. My position is, the FDA will likely give approval, but with either a black box warnings on the side effects, or some other negative. I say this mainly for the hugely negative attitude the FDA had on GERNs drug Imetelstat in general, and especially on the side effect concerns. So while I still think GERNs drug Imetelstat will be a huge winner eventually, I think it isn't worth the risk of holding into the FDA announcement around $4. Either way, June 16(PDUFA date) will be a huge day for GERN.